Invesco Ltd. increased its position in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 1.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,973,128 shares of the company's stock after buying an additional 367,518 shares during the period. Invesco Ltd. owned about 1.62% of Keurig Dr Pepper worth $751,920,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of KDP. ST Germain D J Co. Inc. acquired a new stake in shares of Keurig Dr Pepper in the first quarter worth $27,000. Continuum Advisory LLC increased its position in shares of Keurig Dr Pepper by 82.5% in the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock worth $46,000 after acquiring an additional 602 shares in the last quarter. Global Trust Asset Management LLC acquired a new stake in shares of Keurig Dr Pepper in the first quarter worth $48,000. LRI Investments LLC boosted its stake in shares of Keurig Dr Pepper by 65.6% in the fourth quarter. LRI Investments LLC now owns 1,527 shares of the company's stock valued at $49,000 after purchasing an additional 605 shares during the period. Finally, Riverview Trust Co grew its holdings in Keurig Dr Pepper by 47.7% during the 1st quarter. Riverview Trust Co now owns 1,710 shares of the company's stock valued at $59,000 after purchasing an additional 552 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Wall Street Analyst Weigh In
KDP has been the subject of a number of recent analyst reports. Argus initiated coverage on shares of Keurig Dr Pepper in a report on Wednesday, April 16th. They set a "buy" rating and a $40.00 price target for the company. HSBC upgraded shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and increased their price objective for the company from $36.00 to $42.00 in a research note on Friday, April 25th. Royal Bank Of Canada reiterated an "outperform" rating and set a $42.00 price objective on shares of Keurig Dr Pepper in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. reduced their price target on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a research report on Thursday, July 17th. Finally, Barclays raised their price target on shares of Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $39.77.
Read Our Latest Research Report on KDP
Keurig Dr Pepper Price Performance
Shares of KDP stock traded up $0.19 during midday trading on Tuesday, reaching $34.81. 7,705,961 shares of the company were exchanged, compared to its average volume of 10,111,649. Keurig Dr Pepper, Inc has a 12 month low of $30.12 and a 12 month high of $38.28. The company has a market cap of $47.29 billion, a P/E ratio of 31.08, a PEG ratio of 2.52 and a beta of 0.45. The company's 50 day moving average price is $33.38 and its two-hundred day moving average price is $33.48. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The company had revenue of $4.16 billion for the quarter, compared to the consensus estimate of $4.14 billion. During the same period in the previous year, the firm earned $0.45 EPS. Keurig Dr Pepper's revenue was up 6.1% on a year-over-year basis. On average, sell-side analysts expect that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were issued a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Friday, June 27th. Keurig Dr Pepper's payout ratio is presently 82.14%.
Insider Buying and Selling
In other news, Director De Ven Michael G. Van bought 15,000 shares of the company's stock in a transaction dated Wednesday, June 4th. The shares were acquired at an average cost of $33.20 per share, with a total value of $498,000.00. Following the completion of the transaction, the director directly owned 15,000 shares in the company, valued at approximately $498,000. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares in the company, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 672,000 shares of company stock worth $22,235,760 in the last ninety days. 1.00% of the stock is currently owned by corporate insiders.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Articles

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.